Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

SCN9A Antikörper (C-Term)

SCN9A Reaktivität: Human IHC, WB, IP, FM Wirt: Maus Monoclonal S68-6 unconjugated
Produktnummer ABIN6656787
  • Target Alle SCN9A Antikörper anzeigen
    SCN9A (Sodium Channel, Voltage-Gated, Type IX, alpha Subunit (SCN9A))
    Bindungsspezifität
    • 11
    • 5
    • 3
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    C-Term
    Reaktivität
    • 39
    • 14
    • 10
    • 1
    • 1
    Human
    Wirt
    • 24
    • 16
    • 1
    • 1
    Maus
    Klonalität
    • 26
    • 16
    Monoklonal
    Konjugat
    • 21
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser SCN9A Antikörper ist unkonjugiert
    Applikation
    • 24
    • 21
    • 14
    • 12
    • 12
    • 11
    • 10
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Immunohistochemistry (IHC), Western Blotting (WB), Immunoprecipitation (IP), Fluorescence Microscopy (FM)
    Kreuzreaktivität
    Human, Maus, Ratte (Rattus)
    Aufreinigung
    Anti-NAV1.7 Antibody was purified by Protein G chromatography. A BLAST analysis was used to suggest cross-reactivity with NAV1.7 from Human, Rat, and Mouse based on 100% homology with the immunizing sequence. No cross-reactivity against other Nav channels. Cross-reactivity with NAV1.7 from other sources has not been determined. Channels and Transporters research.
    Immunogen

    Immunogen: Nav1.7 Antibody was produced in mice by repeated immunizations raised against a fusion protein corresponding to the cytoplasmic C-terminus region of human Nav1.7.

    Immunogen Type: Recombinant Protein

    Klon
    S68-6
    Isotyp
    IgG1
    Top Product
    Discover our top product SCN9A Primärantikörper
  • Applikationshinweise

    Immunohistochemistry Dilution: 0.1-1.0 μg/mL

    Application Note: Anti-NAV1.7 Antibody is suitable for use in WB, IP, and IF microscopy. Expect a band approximately ~230 kDa on specific lysates. Specific conditions for reactivity should be optimized by the end user.

    Immunoprecipitation Dilution: User Optimized

    Western Blot Dilution: 1-10 μg/mL

    IF Microscopy Dilution: 1.0-10 μg/mL

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer

    Buffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2

    Stabilizer: 50 % (v/v) Glycerol

    0.09 % (w/v) Sodium Azide
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    RT,4 °C,-20 °C
    Informationen zur Lagerung
    Store vial at -20° C prior to opening. Aliquot contents and freeze at -20° C or below for extended storage. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. This product is stable for several weeks at 4° C as an undiluted liquid. Dilute only prior to immediate use.
  • Target
    SCN9A (Sodium Channel, Voltage-Gated, Type IX, alpha Subunit (SCN9A))
    Andere Bezeichnung
    NAV1.7 (SCN9A Produkte)
    Synonyme
    SCN9A antikoerper, DKFZp459G084 antikoerper, Nav1.7 antikoerper, PN1 antikoerper, mKIAA4197 antikoerper, Scn2a antikoerper, ETHA antikoerper, FEB3B antikoerper, GEFSP7 antikoerper, NE-NA antikoerper, NENA antikoerper, SFNP antikoerper, sodium channel, voltage-gated, type IX, alpha subunit antikoerper, sodium voltage-gated channel alpha subunit 9 antikoerper, sodium channel protein type 9 subunit alpha antikoerper, sodium channel, voltage-gated, type IX, alpha antikoerper, SCN9A antikoerper, LOC100016648 antikoerper, Scn9a antikoerper
    Hintergrund

    Synonyms: ETHA, hNE Na, NENA, PN1, SCN9A, voltage gated sodium channel subunit alpha Nav1.7, peripheral sodium channel 1, neuroendocrine sodium channel, Sodium channel protein type 9 subunit alpha

    Background: Nav1.7 is a voltage-gated sodium channel and plays a critical role in the generation and conduction of action potentials and is thus important for electrical signaling by most excitable cells. Therapeutically, the association of pain insensitivity with the loss of function of a certain sodium channel may have implications. Since Nav1.7 is not present in cardiac muscle or neurons in the central nervous system, blockers of Nav1.7 will not have direct action on these cells and thus can have less side effects than current pain medications. By performing more studies, there is a possibility to develop a new generation of drugs that can reduce the pain intensity in animals.

    Gene Name: Scn9a

    Gen-ID
    6335
    NCBI Accession
    NP_002968
    UniProt
    Q15858
Sie sind hier:
Kundenservice